To further investigate the effect of inhibiting Gas6-Axl signaling in pancreatic cancer progression and metastasis, we performed another in vivo experiment, using our syngeneic orthotopic KPC model (described in Figure 1) using warfarin (instead of a neutralizing anti-Gas6 antibody). This evidence concerns the gene AXL and familial pancreatic carcinoma.